Search
Menu
Meadowlark Optics - SEE WHAT

Watching cancer cells die

Facebook X LinkedIn Email
Marie Freebody, [email protected]

Imagine being able to monitor the effectiveness of a cancer treatment cheaply, easily and, most importantly, without harm to the patient undergoing therapy. That’s exactly what researchers at the University of Notre Dame are hoping will one day be possible, thanks to their pioneering work using a synthetic near-infrared fluorophore that targets dead and dying cells. The ability to evaluate the efficacy of cancer treatments in living patients is almost as important as the cancer therapy itself. The Notre Dame group has successfully demonstrated whole-body optical imaging using a...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: March 2010
    allograft rejectionanticancer researchatherosclerosisBiophotonicsBioScanBradley SmithImagingischemiaJournal of the American Chemical SocietyKodak Multispectral imaging stationmammary tumorMarie FreebodyMRInear-infrared fluorophoreneurodegenerative disordersNewsOpticsPETphosphatidylserineprostate tumorradionuclide imagingSmithUniversity of Notre Dame

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.